ADAMTSL2 is a potential prognostic biomarker and immunotherapeutic target for colorectal cancer: Bioinformatic analysis and experimental verification.

Saved in:
Bibliographic Details
Title: ADAMTSL2 is a potential prognostic biomarker and immunotherapeutic target for colorectal cancer: Bioinformatic analysis and experimental verification.
Authors: Huang, Zhe1 (AUTHOR) 278843749@qq.com, Hu, Xu1 (AUTHOR), Wei, Yiqiu1 (AUTHOR), Lai, Yousheng1 (AUTHOR), Qi, Jiaming1 (AUTHOR), Pang, Jinglin1 (AUTHOR), Huang, Kang1 (AUTHOR), Li, Huagui1 (AUTHOR), Cai, Pengzhu1 (AUTHOR) 278843749@qq.com
Source: PLoS ONE. 5/30/2024, Vol. 19 Issue 5, p1-20. 20p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:19326203
DOI:10.1371/journal.pone.0303909